2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2023 | 0 | 3.763.200 | 0 | 1 | ||
2021 | 0 | 7.057.980 | 0 | 1 | ||
2019 | 0 | 3.915.872 | 252.788 | 1 |
Total number of partners: 61
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 61
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2023-01-01 | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network | Maxima Butterfly | participant | 3.763.200 | 36 |
2021-07-01 | Building a reproducible single-cell experimental workflow to capture tumour drug persistence | PERSIST-SEQ | participant | 7.057.980 | 16 |
2019-10-01 | Exploitation of the SECRETory pathway for cancer therapy to address European research | SECRET | participant | 3.915.872 | 12 |